BR112017011724A2 - ensaio para detectar dpp-4 humana - Google Patents
ensaio para detectar dpp-4 humanaInfo
- Publication number
- BR112017011724A2 BR112017011724A2 BR112017011724-0A BR112017011724A BR112017011724A2 BR 112017011724 A2 BR112017011724 A2 BR 112017011724A2 BR 112017011724 A BR112017011724 A BR 112017011724A BR 112017011724 A2 BR112017011724 A2 BR 112017011724A2
- Authority
- BR
- Brazil
- Prior art keywords
- assay
- dpp
- detect human
- human dpp
- antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562101697P | 2015-01-09 | 2015-01-09 | |
| US62/101,697 | 2015-01-09 | ||
| PCT/US2016/012603 WO2016112261A2 (en) | 2015-01-09 | 2016-01-08 | Assay to detect human dpp-4 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112017011724A2 true BR112017011724A2 (pt) | 2018-05-15 |
Family
ID=56356576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112017011724-0A BR112017011724A2 (pt) | 2015-01-09 | 2016-01-08 | ensaio para detectar dpp-4 humana |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10351630B2 (https=) |
| EP (1) | EP3242686B1 (https=) |
| JP (1) | JP2018502577A (https=) |
| KR (1) | KR20170098941A (https=) |
| CN (1) | CN107206079A (https=) |
| AU (1) | AU2016205188A1 (https=) |
| BR (1) | BR112017011724A2 (https=) |
| CA (1) | CA2970540A1 (https=) |
| HK (2) | HK1244444A1 (https=) |
| IL (1) | IL252528A0 (https=) |
| MX (1) | MX2017008748A (https=) |
| RU (1) | RU2017127182A (https=) |
| SG (1) | SG11201705598VA (https=) |
| WO (1) | WO2016112261A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118359716A (zh) * | 2023-01-18 | 2024-07-19 | 江苏众红生物工程创药研究院有限公司 | 抗cd26抗体及其用途 |
| CN118791612A (zh) * | 2023-04-14 | 2024-10-18 | 江苏众红生物工程创药研究院有限公司 | 靶向cd26的抗原结合蛋白及其药物应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5681718A (en) | 1986-03-14 | 1997-10-28 | Celltech Limited | Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof |
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| US7115555B2 (en) * | 1998-07-09 | 2006-10-03 | Baylor College Of Medicine | Hypohidrotic ectodermal dysplasia genes and proteins |
| US6573096B1 (en) * | 2000-04-01 | 2003-06-03 | The Research Foundation At State University Of New York | Compositions and methods for inhibition of cancer invasion and angiogenesis |
| EP1392361A4 (en) * | 2001-05-11 | 2009-08-05 | Univ Texas | ANTI-CD26 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CD26 EXPRESSIVE CELLS |
| GB0216648D0 (en) | 2002-07-18 | 2002-08-28 | Lonza Biologics Plc | Method of expressing recombinant protein in CHO cells |
| EP1631680A2 (en) | 2003-05-21 | 2006-03-08 | Bayer HealthCare AG | Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4) |
| GB0407315D0 (en) | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
| WO2005075514A2 (en) | 2004-03-10 | 2005-08-18 | Lonza Ltd. | Method for producing antibodies |
| EP1907425B1 (en) * | 2005-07-22 | 2014-01-08 | Y's Therapeutics Co., Ltd. | Anti-cd26 antibodies and methods of use thereof |
| WO2008091814A2 (en) | 2007-01-22 | 2008-07-31 | Wyeth | Assessment of asthma and allergen-dependent gene expression |
| EP2631302A3 (en) | 2008-03-31 | 2014-01-08 | Genentech, Inc. | Compositions and methods for treating and diagnosing asthma |
| US20100221752A2 (en) | 2008-10-06 | 2010-09-02 | Somalogic, Inc. | Ovarian Cancer Biomarkers and Uses Thereof |
| US20130310266A1 (en) * | 2010-09-03 | 2013-11-21 | Immport Therapeutics, Inc. | Methods and Compositions For The Diagnosis And Treatment Of Cancer and Autoimmune Disorders |
| MX2013004212A (es) | 2010-10-15 | 2013-09-02 | Medimmune Ltd | Terapias para mejorar la funcion pulmonar. |
| TWI732259B (zh) | 2010-12-16 | 2021-07-01 | 美商建南德克公司 | 關於th2抑制作用之診斷及治療 |
| EP2710370A4 (en) | 2011-05-18 | 2015-01-07 | Medimmune Llc | METHODS OF DIAGNOSING AND TREATING PULMONARY DISEASES OR DISORDERS |
| US20160363591A1 (en) | 2014-01-27 | 2016-12-15 | Medimmune, Llc | Dipeptidyl peptidase-4 (dpp4/cd26) as a peripheral biomarker of il-13 activation in asthmatic lung |
-
2016
- 2016-01-08 US US14/991,160 patent/US10351630B2/en active Active
- 2016-01-08 HK HK18103970.8A patent/HK1244444A1/zh unknown
- 2016-01-08 AU AU2016205188A patent/AU2016205188A1/en not_active Abandoned
- 2016-01-08 CA CA2970540A patent/CA2970540A1/en not_active Abandoned
- 2016-01-08 RU RU2017127182A patent/RU2017127182A/ru not_active Application Discontinuation
- 2016-01-08 BR BR112017011724-0A patent/BR112017011724A2/pt not_active Application Discontinuation
- 2016-01-08 EP EP16735457.0A patent/EP3242686B1/en not_active Not-in-force
- 2016-01-08 WO PCT/US2016/012603 patent/WO2016112261A2/en not_active Ceased
- 2016-01-08 CN CN201680005264.3A patent/CN107206079A/zh active Pending
- 2016-01-08 KR KR1020177021858A patent/KR20170098941A/ko not_active Withdrawn
- 2016-01-08 JP JP2017536325A patent/JP2018502577A/ja active Pending
- 2016-01-08 HK HK18103568.6A patent/HK1243953A1/zh unknown
- 2016-01-08 MX MX2017008748A patent/MX2017008748A/es unknown
- 2016-01-08 SG SG11201705598VA patent/SG11201705598VA/en unknown
-
2017
- 2017-05-25 IL IL252528A patent/IL252528A0/en unknown
-
2019
- 2019-06-06 US US16/433,174 patent/US20190352425A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3242686A2 (en) | 2017-11-15 |
| HK1244444A1 (zh) | 2018-08-10 |
| AU2016205188A1 (en) | 2017-06-22 |
| WO2016112261A2 (en) | 2016-07-14 |
| IL252528A0 (en) | 2017-07-31 |
| HK1243953A1 (zh) | 2018-07-27 |
| JP2018502577A (ja) | 2018-02-01 |
| SG11201705598VA (en) | 2017-08-30 |
| CA2970540A1 (en) | 2016-07-14 |
| KR20170098941A (ko) | 2017-08-30 |
| RU2017127182A (ru) | 2019-02-11 |
| US20160200832A1 (en) | 2016-07-14 |
| US10351630B2 (en) | 2019-07-16 |
| EP3242686A4 (en) | 2018-06-06 |
| WO2016112261A3 (en) | 2016-09-01 |
| CN107206079A (zh) | 2017-09-26 |
| US20190352425A1 (en) | 2019-11-21 |
| MX2017008748A (es) | 2017-11-17 |
| EP3242686B1 (en) | 2020-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX374652B (es) | Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco. | |
| BR112016029521A2 (pt) | ?kit, dispositivo e método para a detecção de câncer de estômago? | |
| EP4183339A4 (en) | High-reliability analyte detection device | |
| BR112016027475A2 (pt) | kit, dispositivo e método para a detecção de câncer pancreático | |
| MX389083B (es) | Anticuerpos anti-pd-l1 radiomarcados para imagenes de inmuno-pet. | |
| EA201791578A1 (ru) | Панель биомаркеров для обнаружения рака | |
| EP4037552A4 (en) | ANALYTE MEASUREMENT SYSTEM | |
| BR112016028944A2 (pt) | kit ou dispositivo para a detecção de câncer do trato biliar e método de detecção | |
| MX2020000186A (es) | Ensayos para evaluar los niveles de anticuerpos neutralizantes en sujetos tratados con un fármaco biológico y usos de los mismos en medicina personalizada. | |
| BR112016019836A2 (pt) | método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito | |
| BR112016017926A2 (pt) | ensaio para detectar periostina humana | |
| BR112016025627A2 (pt) | biomarcadores e combinações dos mesmos para diagnóstico de tuberculose | |
| BR112017023726A2 (pt) | detecção de fatores de virulência microbiana na cavidade oral | |
| EP3277831A4 (en) | BIOSENSOR SYSTEM FOR THE QUICK DETECTION OF ANALYTES | |
| EP3415912A4 (en) | ANALYT DETECTION PROCEDURE AND REAGENT SET TO DETECT ANALYTES | |
| SA518391028B1 (ar) | Cd37 أجسام مضادة واختبارات للكشف عن | |
| BR112018010764A2 (pt) | método para detectar atividade bacteriana em uma amostra biológica e unidade de detecção correspondente | |
| BR112018013381A2 (pt) | anticorpo especificamente ligante a antígenos derivados de miobacteria ou fragmento ligante a antígeno do mesmo | |
| MX384485B (es) | Deteccion temprana de preeclampsia. | |
| WO2014151290A3 (en) | Assay for predictive biomarkers | |
| BR112017011724A2 (pt) | ensaio para detectar dpp-4 humana | |
| MX384636B (es) | Método para detectar anticuerpos neutralizantes contra la insulina humana recombinante en suero humano. | |
| PL406989A1 (pl) | Profil mikro RNA we krwi jako test wykrywania raka płuca | |
| WO2017053703A3 (en) | Composition and methods for assessing sensitivity and specificity of antibody detection reagents | |
| EP3306319A4 (en) | TEST OBJECT DETECTION PROCEDURES AND IMMUNOASSAY INSTRUMENT AND MONOCLONAL ANTIBODY THEREFOR |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |